000			03356cam a22004218i 4500
001			22904713
003			BJBSDDR
005			20241113093037.0
007			ta
008			221217s2023 nyu b 001 0 eng
010			_a 2022057318
020			_z9780393540956
020			_z0393540952
040			_aDLC _beng _erda _cDLC
041			_aeng
042			_apcc
043			_an-us--- _an-us-ca
050	1	4	_aHD 9999 _bV291f 2023
100	1		_aVardi, Nathan _939316
245	1	0	_aFor blood and money : _bbillionaires, biotech, and the quest for a blockbuster drug / _cNathan Vardi.
250			_aFirst edition.
264		1	_aNew York, N.Y. : _bW.W. Norton & Company, _c2023
300			_a271 pages ; _c24 cm.
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
504			_aIncludes bibliographical references and index.
505	0		_aPrologue : sidelines -- The surfing Scientologist -- Man of science -- The takeover -- Starting fresh -- Wall Street -- The Big Easy -- The next phase -- Fired -- Partners -- Going Dutch -- Genius -- Truffle pig -- Master switch -- Approved -- Demoted -- Billions -- The whirlwind -- A biotech odyssey -- Graduation day -- Epilogue : head-to-head.
520			_a"For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how the core team-denied their share of the profits-went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time. In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks-and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they're onto something big. What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi's narrative immerses readers in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction read, For Blood and Money illustrates why it's so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine"-- _cProvided by publisher.
650		0	_aBiotechnology industries _zCalifornia.
650		4	_aIndustria biotecnológica _99731
650		4	_aBiotecnología industrial _939471
650		0	_aDrug development _zUnited States.
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
942			_2lcc _cBK
946			_idpf
999			_c122375 _d122375